Tristel (TSTL) Competitors

Advanced Medical Solutions Group (LON:AMS) and Tristel (LON:TSTL) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, risk, analyst recommendations, earnings, valuation, profitability and institutional ownership.

Which has better earnings & valuation, AMS or TSTL?

Advanced Medical Solutions Group has higher revenue and earnings than Tristel. Tristel is trading at a lower price-to-earnings ratio than Advanced Medical Solutions Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Advanced Medical Solutions Group	£132.18M	3.40	£11.22M	£5.16	40.31
Tristel	£42.24M	4.13	£6.54M	£13.66	26.71

Does the media favor AMS or TSTL?

In the previous week, Advanced Medical Solutions Group and Advanced Medical Solutions Group both had 1 articles in the media. Advanced Medical Solutions Group's average media sentiment score of 1.43 beat Tristel's score of 0.75 indicating that Advanced Medical Solutions Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Advanced Medical Solutions Group	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Tristel	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals and insiders believe in AMS or TSTL?

58.2% of Advanced Medical Solutions Group shares are owned by institutional investors. Comparatively, 50.4% of Tristel shares are owned by institutional investors. 3.1% of Advanced Medical Solutions Group shares are owned by insiders. Comparatively, 4.9% of Tristel shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Which has more risk and volatility, AMS or TSTL?

Advanced Medical Solutions Group has a beta of 0.74, suggesting that its share price is 26% less volatile than the S&P 500. Comparatively, Tristel has a beta of 0.23, suggesting that its share price is 77% less volatile than the S&P 500.

Is AMS or TSTL a better dividend stock?

Advanced Medical Solutions Group pays an annual dividend of GBX 2 per share and has a dividend yield of 1.0%. Tristel pays an annual dividend of GBX 13 per share and has a dividend yield of 3.6%. Advanced Medical Solutions Group pays out 38.8% of its earnings in the form of a dividend. Tristel pays out 95.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Do analysts recommend AMS or TSTL?

Advanced Medical Solutions Group presently has a consensus target price of GBX 287.50, indicating a potential upside of 38.22%. Tristel has a consensus target price of GBX 400, indicating a potential upside of 9.59%. Given Advanced Medical Solutions Group's stronger consensus rating and higher possible upside, analysts plainly believe Advanced Medical Solutions Group is more favorable than Tristel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Advanced Medical Solutions Group	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Tristel	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Is AMS or TSTL more profitable?

Tristel has a net margin of 15.47% compared to Advanced Medical Solutions Group's net margin of 8.49%. Tristel's return on equity of 20.43% beat Advanced Medical Solutions Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Advanced Medical Solutions Group	8.49%	4.57%	2.35%
Tristel	15.47%	20.43%	9.89%

Summary

Advanced Medical Solutions Group beats Tristel on 10 of the 17 factors compared between the two stocks.